Dr. Ramaswamy is the Tucker Gosnell Investigator andAttending Physician at the Massachusetts General Hospital Cancer Center, AssistantProfessor of Medicine at Harvard Medical School, the Harvard Cancer Center,Harvard Stem Cell Institute, and Broad Institute of Harvard & MIT. He is anactive member of the American Society for Clinical Oncology, American Societyof Hematology, American College of Physicians, and American Society forClinical Investigation.
We investigate the molecular and cellular basis of cancer cell metastasis and drug resistance, with an eye towards translating findings into new diagnostic and treatment strategies for cancer patients.
Learn more about the Ramaswamy Lab.
Sridhar Ramaswamy, MD, awarded a Research Innovation Grant to fund his lab’s work on the mechanisms of cancer cell survival, metastasis, drug resistance, and dormancy.
The ASCI is an honor society of physician-scientists, who translate findings in the laboratory to the advancement of clinical practice.
The Kimmel Scholar Awards were created in 1997 to further the careers of gifted, young scientists involved in cancer research.
Each year, alumni of the HHMI-National Institutes of Health Research Scholars Program and the HHMI Research Training Fellowships for Medical Students are invited to apply for Early Career Awards as they begin their careers as physician-scientists.
Mass General researchers believe computational biology will lead to more accurate diagnosis of a broad range of conditions and improved personalized treatments.
Cancer begins its spread much earlier than thought, hijacks healthy cells to help it proliferate, and activates a dormant embryonic program that gives it license to travel.